Respiratory involvement and immune status in yusho patients. by Nakanishi, Y et al.
Environmental Health Perspectives
Vol. 59, pp. 31-36, 1985
Respiratory Involvement and
Immune Status in Yusho Patients
by Yoichi Nakanishi,* Nobuaki Shigematsu,*t
Yukio Kurita,* Kenichi Matsuba,* Hideki Kanegae,*
Shuzo Ishimaru* and Yasushi Kawazoe*
Clinical and experimental studies on respiratory involvement and alterations in immune status were
carried out. Respiratory distress occurring in these patients has improved gradually for 14 years but still
remains.
Copious expectoration at an early stage ofthe disease may be related to the factthat a numberofdiscrete
polychlorinated biphenyls (PCBs)aredistributedthroughout thelungparenchyma. Foraccumulation inthe
bronchial mucosa, structural requirements and specific dose dependence ofPCBs have been clearly shown;
however, pathological and physiological studies have indicated that respiratory involvement in Yusho is
mainly small airway disease that may be caused by involvement of cellular component (Clara cells) in
bronchioles and/or associated infection.
Respiratory distress is often exacerbated by viral or bacterial infection. Changes in the immune status in
PCB and polychlorinated dibenzofuran (PCDF) poisoning are as follows: IgA and IgM in the serum are
decreased at an early stage ofthe disease and then return to normal; suppression ofcellular immunity was
reported in Taiwanese patients and some may remain in the later stages of the disease, as shown in our
patients. PCDFs now appear to be the main causal agents in Yusho. Rats given PCDFs showed necrosis of
the Clara cells in bronchioles and marked thymus atrophy, while few such changes were noted in rats given
PCBs. Therefore, further examination is needed for the difference of the toxic effects between two
compounds.
Introduction
Since 1968, patients with polychlorinated biphenyl
(PCB) and other chemical poisoning began to appear
throughout the western part ofJapan. The cause was
traced and confined to the contamination of edible
rice-bran oil by PCBs used as a coolant in the manufac-
turing process (1). Since then, the disease has been
called "Yusho," which means "the oil disease' Unusual
skin lesions and the other symptoms in Yusho or PCB
poisoning vary a great deal (2,3). Until a year after
onset of the disease, respiratory symptoms had been
neglected because of a lack of awareness of their
relationship to PCB poisoning. Thereafter, we were
asked to participate in a study on clinical, laboratory
and pathological findings on respiratory involvement in
the patients.
As aresult, it has been observed that the incidence of
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respiratory symptoms correlated well with the concen-
tration ofPCBs in the blood and the definite PCB peaks
were always detected in the sputa (4). Respiratory
distress was often exacerbated by viral or bacterial
infection, persisting for more than a half year in about
half of the patients examined (4). Therefore, immuno-
suppressive activity of these toxic compounds was
observed clinically and experimentally.
Respiratory distress occurring in these patients has
improved gradually over 14 years but still remains; and
furthermore, three interesting facts were found to add
to this field ofthe study: first, structural requirements
for accumulation in the bronchial mucosa reported by
Brandt et al. (5,6); second, polychlorinated dibenzo-
furans (PCDFs) included in the rice oil can be hundreds
to thousands of times more potent than PCBs or
polychlorinated quaterphenyls (PCQs) as inducers of
various clinical manifestations (7); third, the furan
moiety was covalently bound preferentially to the
nonciliated bronchiolar (Clara) cells (8). Therefore, we
reviewthe disease andreport new facts in consideration
of the above-mentioned problems.NAKANISHI ET AL.
Materials and Methods
Clinical Study
A total of 401 patients with PCB poisoning form the
basis ofour study. They were subjected to the following
examinations: an assessment of subject symptoms,
chest x-rays, pulmonary function, microbial study ofthe
sputum and determination ofimmunoglobulin levels and
PCB concentration and type (4) in serum and sputum.
The results ofthese examinations done prior to 1975 (7
years after the onset of the disease) have already been
reported, and a pathological study done on the lungs
from seven autopsy cases and from rats given PCBs was
also described (4).
In this report, early subjective symptoms and physi-
cal findings characteristic to the disease were reviewed
in detail, and the clinical course and the latest status in
pulmonary function and immunological suppression in
the patients observed in February and March 1983 were
also described.
Table 1. Clinical course of respiratory symptoms (cough and
sputa) in 79 cases, which were followed up for 11 years.
Symptoms 1972-1973 1974-1975 1977-1978 1983
Positive
Exacerbateda 10 (21%) 13 (16%) 14 (26%) 4 (9%)
Unchangeda 18 (38%) 39 (49%) 18 (33%) 30 (70%)
Improveda 7 (15%) 15 (19%) 12 (22%) 0
Negative 12 (26%) 12 (15%) 10 (19%) 9 (21%)
aThe change ofsymptoms over the course was compared with those
in the late check-up year.
Table 2. Serial serum immunoglobulin levels in adult
Yusho patients.
Level, mg/dLa
Date of exam. Cases IgG IgM IgA
Mar.-June 1970 28 1655 ± 414* 127 + 57+ 151 ± 77+
July-Oct. 1970 27 1843 ± 628* 186 ± 92 286 ± 100+
Jan.-Mar. 1971 9 1516 ± 471* 225 ± 103* 253 ± 149
June-Aug. 1971 13 1571 ± 341 185 ± 65 203 ± 64
Oct.-Dec. 1971 24 1586 ± 604* 172 ± 88 232 ± 70
Jan.-Mar. 1972 29 1340 ± 447 166 ± 91 206 ± 97
Nov.-Dec. 1980 15 1307 ± 239 153 ± 61 199 ± 72
Control 57 1243 ± 329 170 ± 54 207 ± 96
aMean ± SD.
*Significant increase (p<0.01) compared to control.
tSignificant decrease (p<0.01) compared to control.
Animal Experiments
Male rats of the Sprague-Dawley strain, weighing
about 220 g, were given, by gastric intubation, 2.5mgof
Kanechlor 400 (KC 400) in 2 mL ofedible oil three times
perweek (Group I PCBs) and 0.25 mg ofPCDF in 2 mL
of oil (Group I PCDFs) and only 2 mL of oil (Group I
control), and the same dose six times per 2 weeks
(Group II PCBs, PCDFs and control). Each group ofsix
animals was killed at 7 days (Group I) and 14 days
(Group II) after the first ingestion. Tissues were
prepared for light and electron microscopy.
Results
Respiratory Symptoms and Signs
Approximately a year after onset of the disease we
were asked to see the patients. About half of the
patients complained of expectoration; some showed
continual mouthful expectoration and used a lot of
tissue paper which filled the waste basket within a few
hours. Such patients proved to have high concentration
of PCBs in the blood (analysis of blood PCBs in Yusho
patients was started in 1973, 5 years after the onset of
the disease).
Respiratory physical findings in the patients were
quite different from those in usual chronic bronchitics:
that is, many patients showed no crackles except for
smoking patients, even when they expectorated a
mouthful ofsputum, and some patients showed wheezes
without radiological, physiological or immunological
evidence ofbronchial asthmaorpulmonary emphysema.
Table 3. Pulmonary function test in 12 nonsmoking patients with
reticulolinear shadows about 1 year after onset of respiratory
distress and at follow-up.a
Measurement 1970 1973-1974 1983
VC/predicted VC, % >100 5 6
> 90 1 5
> 80 1
FEV1/FVC, % 2 80 3 9
> 75 3 3
Vn,,50, L/sec 4.0 6 2
>2.0 6 4
Vma,?, L/sec ¢1.5 5 2
¢1.0 5 3
20.7 2 1
Pa 02, mm Hg 85 3 4 5
> 70 2 7 1
> 60 1 1 0
aAges of patients ranged between 30 and 49 years.
Table 4. Lymphocyte subsets and function by OKT series and PHA in patients with Yusho.
Subjects OKT-3 OKT-4 OKT-8 OKT-4/8 PHA
Control 68.3 ± 8.6 41.2 ± 5.7 26.0 ± 5.0 1.63 ± 0.45 303 ± 70
Yusho (n = 38) 63.8 ± 8.0 42.7 ± 8.1 22.8 ± 6.2 1.98 ± 0.82 268 ± 96
<10A (n = 28)' 63.1 ± 9.1 42.0 ± 8.8 23.5 ± 5.5 1.84 ± 0.74 286 ± 58
>10A (n = 10)a 65.6 ± 6.1 44.7 ± 6.3 21.0 ± 7.3 2.44 ± 0.93 248 ± 97
a<1A, >1OA indicate PCB concentration and type (4) in the blood.
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Clinical Course and PCBs + . > e .
in Blood and Sputum
Respiratory distress occurring in these patients im-
proved gradually over 10 years after onset ofthe disease
(Table 1), but within 5 years respiratory symptoms
persisted in most cases (9), especially in those with high t
blood concentrations of PCBs and with signs of chroni- AA
cally infected airways. PCB concentration in blood was
little changed from 1973 (5 years after the onset of the
disease) to 1983 (10). PCB concentration in sputa was
about one-third to one-tenth ofthe blood concentration.
In a 66-year-old male patient with bilateral cicatrical
thickening ofthepleura due to tuberculosis which healed
in 1942, respiratory insufficiency and CO2 narcosis had ;
developed three times because of airflow obstruction
exacerbated by bacterial infection. PCB concentration
in the blood and sputum was high (27 and 8 ppb, A
respectively) in 1975. Chronic bronchobronchiolitis,
probably related to PCB discharge from airways with Jr .LM
secondary infection, was clinically considered by contin-
uous proof of PCB and Pseudomonas aeruginosa in
sputum. Continuous inhalation of antibiotics was pre- IN scribed until December 1976. After cessation of the
antibiotics due to renal complication, his respiratory
symptoms worsened and he died of pulmonary insuf-
ficiency in March 1977. At autopsy diffuse fibrous
adhesion of bilateral pleurae was present. In the lung
were mild chronic tracheo-bronchobronchiolitis (and I e
severe edema) (11). The amount of PCB in the liver, .w0
fatty tissue and brain was not so increased, but the g <' P \il
chromatogram pattern was specific to Yusho patientst
Pulmonary Function Test . B
The results in 12 nonsmoking patients are presented , 5 \ 9
in Table 2. Vital capacity (VC) and the FEV1/FVC ratio a.o
were almost normal, but arterial oxygen tension(P02) Nfl't & #X # l-
decreased in eight patients and maximal expiratory flow j
at 50 and 25% of vital capacity (Vmax 50 and Vmax 25)
showed mild decreases in about half of the patients; in e
the latter, both inspiratory and expiratory rhonchi were , '8 , >= {-/
audible at all times in 1970 to 1974 (4). The same tests . X , , * ,
were again run in 1983; and slight improvement was ^2t*iJ ^
noted, and rhonchi were not audible at this time. .,
Immunological Study J &.
Immunoglobulin levels of the patients were first 7
determined in 1970, when the IgA andIgM levels in the ,
serum decreased and the IgG level increased. All were 4. .4
restored to normal in 1972, except in three cases (one . t -
adult and two children) where the IgA level remained C
low (4). Though no statistically significant relationship
between IgA levels and clinical symptoms was detected, FIGURE 1. Tissuefromlungs ofratsgivenPCDFSfor2weeks. Clara b
levels of less than 100 mg/100 mL were found in 5 of cells are hyperplastic but more scarcely seen in terminal
bron- IgA . . chiole, probably due to (A) necrotic changes, compared with (B) 29 cases with respiratory symptoms but none in 24 hyperplastic changes in rat lungs given PCB for 2 weeks and (C)
cases without. The IgM levels were significantly lower controls. H-E stain x 80.
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FIGURE 2. Ultrastructural view of rat lungs given PCDFs for 2 weeks. Necrosis of the Clara cells is clearly seen. x2600.
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FIGURE 3. Ultrastructural view of rat lungs given PCB. A proliferation ofagranular endoplasmic reticulum in the cytoplasm is shown, but
no necrotic changes are present. x 5000.
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in patients with severe dermatological symptoms, while I -Z
the IgAlevels insputumwerenotlow(4). Immunoglobu-
lin levels were again examined in 1980, when all were in
normal range (Table 3).
Since T-cells appeared to be sensitive to PCDF
poisoning in the animal experiment described below, the
effect of PCDF on two T-cell subsets, i.e., suppressor
T-cells and helper T-cells were studied. Table 4 shows
that the percentage of helper T-cells (OKT-4) was
slightly increased but that ofsuppressor T-cells (OKT-8)
was slightly decreased in the patients with higher blood
PCB concentration (> 10A). Theresponse to nonspecific
mitogen-PHA was also lowered in the same patients. '
Pathologic Changes intheLungs andThymus
Pathological study of lung specimens from seven
autopsy patients disclosed lymphocyte infiltration in
bronchial and bronchiolar walls and macrophage infiltra-
tioninalveoli, particularlyaroundbronchiolesassociated
with alveolar collapse in four patients dying at 13 to 48
years of age (4). Focal hemorrhage and/or pulmonary
edema and pleural and pericardial effusion or adhesion
were also detected in three patients who died within 4 ;-.
to 12 months after the onset of the poisoning (12,13). e V X
Marked hyperemia, atelectasis, and alveolar hemor-
rhage were noted in a stillborn case (14). ;
In rat lungs given PCDFs, necrosis ofthe Clara cells a.'
was seen mildly at a week and clearly at 2 weeks after
the start of the experiment (Figs. 1A and 2). Other
histologic changes were mild pulmonary edema and 'e ;
vascular congestion at 2weeks (Fig. 1A). These findings
were mild in rats given PCBs (Figs. 1B and 3).
Rat thymus given PCDFs decreased in size, and
microscopic features showed severe atrophy (Fig. 4A),
but rats given PCBs showed the same type of changes r i
but of less severity (Fig. 4B).
Discussion
Cause, Clinical Symptoms and
Pathophysiological Changes in Yusho
The causative agents proved to be PCBs, PCQs and
PCDFs by chemical and activation analysis. Recent
studies in mice showed that a number ofdiscrete PCBs
were not taken up by the bronchi but were distributed
very evenly throughout the lung parenchyma (5).
However, specific dose dependence (15) and structural
requirements (6) of PCBs were shown to exist for ; '
accumulation in the mouse bronchial mucosa. A large
amount ofexpectoration at an early stage ofthe disease
may relate to this. Nevertheless, pathophysiological
findings in the patients reveal that respiratory involve-
ment in Yusho is mainly small airways disease which
maybe caused by involvement ofthe cellular component atrophy;
in bronchioles and/or associated infections. Recent atrophy,
studies that appear to be related to these problems are x 80.
A
B
C
Thymic tissue (A) of rats given PCDFs shows marked
(B) thymic tissue of rats given PCB shows mild
compared with (C) control rat thymus. H-E stain,
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the following. The main causative agents inducing
Yusho are PCDFs (7), and a furan derivative (4-ipo-
meanol) that produces a characteristic lesion in several
laboratory animal species which is necrosis of the
nonciliated bronchiolar (Clara) cells. The initial damage
to this cell population appears to be highly selective.
Relatively late occurring manifestations oflung toxicity
after administration of comparatively large doses of
furan derivatives sometimes may include pulmonary
edema, pleural effusions, vascular congestion and
hemorrhage (8). Lungs of rats given PCDFs in this
study also showed the same pathologic features as those
in 4-ipomeanol (furan derivative) intoxication.
Alterations in Immune Status
Respiratory distress is often exacerbated by viral or
bacterial infection. In the latter, Gram negative bacilli
were often detected and found to persist in about halfof
the cases examined (4).
The changes in immune status in Japanese and
Taiwanese patients (16) were almost the same in
humoral immune response; that is, IgA and IgM in the
serum decreased in both Japanese and Thiwanese
patients about 2 years after the onset of the disease,
and then returned to normal after 3 years.
Yau-Chin Lu (16) reported low OKT4/8ratio (namely,
lowhelper/suppressorT-cellratio) and enhanced respon-
siveness to nonspecific mitogen-PHA in Chinese PCB-
poisoned patients 3 years after onset. Conversely, our
data showed, inJapanese Yusho patients 14 years after
onset, high OKT 4/8 ratio and lowered responsiveness to
PHA. The differences may be attributed to phenomena
in the course of the disease.
Data onthe effect ofPCBs onthe immune mechanism
are sparse, although a general lowering of gamma-
globulin levels in nonpregnant rodents has been noted
by some authors (17-19), and the suppression ofcellular
immunity such as the delayed-type skin repsonse to
streptokinase and streptodornase was reported in PCB-
poisoned patients (20).
In our experimental animals, feeding ofPCBs caused
mild thymus atrophy, and feeding of PCDFs, marked
atrophy. As mentioned above, PCDFs are the main
causative agents in Yusho. Therefore, further examina-
tion is needed to ascertain in detail the difference in
effects between PCBs and PCDFs.
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